CTRI/2024/07/070861
Not yet recruiting
Phase 2
A comparative clinical trial to study the effect of Triphaladi ghrita and albendazole in the management of Krimi roga in children. - NI
Dr Puja Kumari0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Puja Kumari
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with sign and symptoms of krimi roga.
- •Age 3 to 12 years.
Exclusion Criteria
- •Patients not willing for trial.
- •Patients affected with any systemic disease.
- •Patients on any other medication.
- •Age more than 12 years and less than 3 years.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Evaluation of PDL laser for the treatment of cutaneous leishmaniasisCutaneous leishmaniasis.Cutaneous leishmaniasisIRCT2014072018536N1Dr Radmanesh clinic38
Completed
Phase 3
Effect of Na/K citrate on contrast media-induced acute kidney injuryAcute renal failure.Acute renal impairmentIRCT2015011618389N3Qom University of Medical Sciences and Health Services Vice chancellor400
Completed
Phase 3
Effect of Nicorandil on contrast media-induced acute kidney injuryAcute renal failure.Drug- and heavy-metal-induced tubulo-interstitial and tubular conditionsIRCT2016033118389N4Qom University of Medical Sciences and Health Services Vice chancellor128
Not yet recruiting
Phase 2
To study the effect of yashtimadhu ghrita application in treatment of mukhapak 9Apthous ulcer)Health Condition 1: K137- Other and unspecified lesions of oral mucosaCTRI/2022/03/041429Dr Harshada Patange
Recruiting
Phase 2
The effect of clinical follow-up on quality of life and re-admission of patients with heart failureIRCT20100911004728N3Vice Chancellor for research of Kerman University of Medical Sciences130